Dr Reddys Laboratories (RDY) Consolidated Net Income (2009 - 2026)
Dr Reddys Laboratories (RDY) recorded Consolidated Net Income of $45.93 million in the quarter ended Jun 30, 2026, down 72.1% from $164.71 million a year earlier and down 98.1% from the prior quarter.
Dr Reddys Laboratories (RDY) Consolidated Net Income (2009 - 2026) Analysis & Trends
On a TTM basis, Dr Reddys Laboratories' Consolidated Net Income came in at $4.44 billion as of Jun 30, 2026, up 780.9% year-over-year; for the year ended Mar 31, 2026, it came in at $452 million, down 33.3% from the prior year.
- Annual Consolidated Net Income has a five-year compound annual growth rate of 13.9% (years ended Mar 2021 to Mar 2026).
- Across earlier years, Consolidated Net Income came in at $677.3 million in the year ended Mar 31, 2025 (+1.4%), $668 million in the year ended Mar 31, 2024 (+21.9%), $548 million in the year ended Mar 31, 2023 (+76.2%) and $311 million in the year ended Mar 31, 2022 (+31.8%).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Consolidated Net Income since the quarter ended Mar 31, 2025.
- On a year-over-year basis, Consolidated Net Income rose in two of the last five quarters, with growth averaging 176.6%.
- Peak year-over-year performance for Consolidated Net Income in the last five years was growth of 964.6% in the quarter ended Dec 31, 2025, against a decline of 89.8% in the quarter ended Dec 31, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.46 billion (quarter ended Mar 31, 2026), $1.77 billion (quarter ended Dec 31, 2025) and $163.58 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Dr Reddys Laboratories | 10.22 Bn | 9.41 Bn | 396.53 Mn | 45.93 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.93 Mn |
| Mar 31, 2026 | 2.46 Bn |
| Dec 31, 2025 | 1.77 Bn |
| Sep 30, 2025 | 163.58 Mn |
| Jun 30, 2025 | 164.71 Mn |
| Mar 31, 2025 | 12.63 Mn |
| Dec 31, 2024 | 166.26 Mn |
| Sep 30, 2024 | 160.17 Mn |
| Jun 30, 2024 | 166.87 Mn |
| Mar 31, 2024 | -6.71 Mn |
| Dec 31, 2023 | 11.91 Mn |
| Sep 30, 2023 | 179.04 Mn |
| Jun 30, 2023 | 178.00 Mn |
| Mar 31, 2023 | 169.00 Mn |
| Dec 31, 2022 | 117.00 Mn |
| Sep 30, 2022 | 152.00 Mn |
| Jun 30, 2022 | 154.01 Mn |
| Mar 31, 2022 | 11.64 Mn |
| Dec 31, 2021 | 48.00 Mn |
| Sep 30, 2021 | 93.00 Mn |
Dr Reddys Laboratories Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();